Here, we describe a step-by-step description of transhiatal esophagectomy and the development of a low-cost single-port device for a transcervical approach in a minimally invasive transhiatal esophagectomy.
Esophagectomy remains the preferred option to achieve curative treatment in advanced esophageal cancer, but the choice of surgical approach remains controversial. A transthoracic approach may improve lymph node dissection, but it has considerable morbidity and respiratory complications. Transhiatal access has been demonstrated as an efficient means of minimizing post-operative complications. Minimally invasive transhiatal esophagectomy may reduce operative trauma and morbidity as well as enhance postoperative recovery with no compromise in cancer recurrence or survival. Nevertheless, it has a technical limitation in terms of cervical esophagus dissection. Thus, a low-cost single-port device was developed to complete upper mediastinal dissection by a transcervical approach during minimally invasive transhiatal esophagectomy. This device uses a nasogastric tube, a number-eight sterile glove, a sterile sponge, and 3 permanent 5-mm trocars. The step-by-step process of transhiatal esophagectomy and the development of this device are described. This technique allows for the dissection of the upper mediastinum, as well as the esophagus over the aortic arch and behind the superior portion of the trachea. The harvesting of lymph nodes along the left recurrent laryngeal nerve and paratracheals was improved.
There are multiple options for the treatment of esophageal cancer, which involve endoscopy, surgery1, neoadjuvant, and definitive treatment with chemoradiotherapy2. Esophagectomy is the most important element in the curative treatment of patients with advanced esophageal cancer3, and the two main approaches currently used for surgical treatment are transthoracic esophagectomy (TTE) and transhiatal esophagectomy (THE). However, the choice of approach remains controversial. Since TTE requires pulmonary collapse during surgery, more frequent pulmonary complications are to be expected than in a transhiatal approach. Minimally invasive techniques are used to reduce access trauma to the lungs and others structures of the thorax, but they do not decrease the morbidity in comparison to THE. Thus, minimally invasive THE has become a more attractive option; however, the upper esophagus and upper mediastinum are difficult areas to dissect due to blind areas, and cervical incision might be not enough to allow a safe dissection of the upper part.
Laparoscopic THE reduces morbidity4 and enhances postoperative recovery with no compromise in cancer recurrence or survival5. THE has been shown to decrease the hospital stay, hospital mortality, surgical time, and blood loss. Furthermore, TTE has a higher risk of pulmonary complications. The patient’s stay in the intensive care unit is significantly longer after transthoracic resection, and hospital stay is also significantly prolonged.
However, there is an issue with THE regarding the lymph node dissection, particularly in the upper mediastinum, which is a blind area. This results in a risk of tracheal and vascular lesions during the surgery. Tokairin6 et al. and Fujiwara et al. described a single-port mediastinoscopic method for upper mediastinal dissection in esophageal cancer surgery. This technique enabled clear visualization of the structures around the aortic arch and safe lymphadenectomy7. A low-cost single-port device was developed to improve upper mediastinal dissection using a left transcervical mediastinoscopic approach, which was used to improve the visibility and dissection in the upper mediastinum around the aortic arch. The aim of this project is to describe the step-by-step process of a laparoscopic THE completed using a mediastinoscopy cervical approach with a low-cost single-port device in a rendezvous technique.
The surgical procedure and the protocol were explained to the patients, and they signed a consent form. This study was approved by the local ethics committees of the institutional review board and informed consent were collected from patients, register number 1688/20. Patients who underwent transhiatal esophagectomy were included in the protocol, while those patients who underwent a transthoracic approach were excluded.
1. Production of low-cost single-port device
2. Laparoscopic and transhiatal procedure
3. Transcervical procedure
The LoCoSP device is a useful tool for safely dissecting the structures of the upper mediastinum. Direct visualization of the cervical and upper thoracic esophagus allows for safe dissection with less risk of tracheal injury and hemorrhage from tearing of the larger vessels, in addition to improving the lymphadenectomy of the left recurrent laryngeal and paratracheal nodes.
From 2018 to 2020, 12 patients with distal esophageal carcinoma (2 squamous cell carcinoma and 10 adenocarcinoma) were submitted to laparoscopic transhiatal esophagectomy with transcervical access to cervical esophagus dissection and lymphadenectomy. The median age was 62 (60 ± 85) years old, only one patient was female. There was no chordal palsy, bleeding, tracheal damage related to the transcervical access. One anastomotic fistula occurred with no clinical complications, spontaneous drainage through the cervical incision. The median operation time was 360 min (300 ± 420 min), and the operation time of the transcervical dissection of the cervical esophagus was 60 min (40 ± 110 min). The median hospital stay was 10 days (9 ± 12 days). All cases were performed with the LoCoSP device (Table 1).
Figure 1: Low-cost single-port device Please click here to view a larger version of this figure.
Figure 2: Low-cost single-port device (note the triangulation of the three trocars) Please click here to view a larger version of this figure.
Figure 3: Low-cost single-port device into the cervical wound Please click here to view a larger version of this figure.
Total Patients | 12 |
Median Age (years) | 62 |
Number Anastomotic fistula | 1 |
Median operation time (minutes) | 360 |
Median operation time transcervical dissection (minutes) | 60 |
Median Hospital stay (days) | 10 |
Table 1: Surgery results using low cost single-port device
The LoCoSP device allows for safer surgery using a transcervical approach in minimally invasive THE. This is accomplished by improving the recognition and dissection of the esophagus, trachea, and the aortic arch under magnified vision. The advantages of THE are amplified. In addition to allowing surgery with less morbidity and fewer pulmonary complications, this technique can improve the dissection of left paratracheal and recurrent lymph nodes. Another advantage of this technique is that it is possible to reduce the risk of tracheal and vascular injury during THE.
Damage of the posterior wall of the trachea or the main bronchi rarely occurs during esophagectomy, and the reported rates are 1.35%8 to 1.8%9. However, when it does happen, the prognosis is unfavorable10. Dissection with a single-port mediastinoscopic cervical approach allows for direct visualization of the upper esophagus and the trachea, which could possibly decrease the chances of injury to the airways. Finally, the production of the LoCoSP device is easy, and it can be reproduced in other centers. The device is produced using cheap and widely available instruments in any operating room. An important limitation of the technique is the leakage of air through the cervical wound, during the dissection of the upper mediastinum. Nevertheless, the method is still an experimental method, and the real benefit of using the LocOSP device must be studied and analyzed in a greater number of patients.
The authors have nothing to disclose.
None.